MAPK3 and melanoma: To mine the behind mechanism of EphA3-driven melanoma progression, we tested whether EphA3 silence impacts the ERK signaling cascade since anti-EphA3 antibodies could retard glioblastoma progression by modifying ERK1/2 signaling pathway [7].